Cardeas Pharma, Inc.

City:

Seattle, Washington

Country:

United States

Published Applications:

Last publication date:

2014-08-07

Patent Grants:

Last grant date:

2019-11-12

Top Inventors for applications by Cardeas Pharma, Inc.

These are the the leading inventors for applications assigned to Cardeas Pharma, Inc.:

Alan Bruce Montgomery 3 Medina, WA United States
Alan Bruce Montgomery 1 Seattle, WA United States

Recent patent applications by Cardeas Pharma, Inc.

Cardeas Pharma, Inc. based in Seattle, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-08-07 ✅ Patent 10,471,083 granted on 2019-11-12

US20140221302A1

Human necessities

Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

#2 | 2013-11-14 ✅ Patent 8,636,983 granted on 2014-01-28

US20130303476A1

Human necessities

Aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

#3 | 2013-11-14 ✅ Patent 8,636,984 granted on 2014-01-28

US20130302423A1

Human necessities

Aerosol formulation of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

#4 | 2013-01-17 ✅ Patent 8,603,439 granted on 2013-12-10

US20130014759A1

Human necessities

Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis

Also check out Cardeas Pharma Inc.'s (Seattle, United States) applicant profile with 4 patent applications submitted.

AssigneeID:

73958 ⎘